Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study-Reference-Cited by-同舟云学术

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

Published:2020-12 Issue: Volume:184 Page:104763
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Sloan Susan E.,Szretter Kristy J.,Sundaresh Bharathi,Narayan Kristin M.,Smith Patrick F.,Skurnik David,Bedard Sylvain,Trevejo José M.,Oldach David,Shriver Zachary

Funder

Visterra, Inc

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference41 articles.

1. Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies;Balasingam;Int. J. Infect. Dis.,2016

2. The hemagglutinin stem-binding monoclonal antibody VIS410 controls influenza virus-induced acute respiratory distress syndrome;Baranovich;Antimicrob. Agents Chemother.,2016

3. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial;Beigel;Lancet Respir. Med.,2019

4. Advances in respiratory virus therapeutics - a meeting report from the 6th isirv Antiviral Group conference;Beigel;Antivir. Res.,2019

5. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study;Beigel;Lancet Respir. Med.,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA);Clinical Infectious Diseases;2024-07-22

2. Fundamental limits to the effectiveness of traveler screening with molecular tests;2024-07-12

3. Modeling the transmission mitigation impact of testing for infectious diseases;Science Advances;2024-06-14

4. Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody;Frontiers in Immunology;2024-05-30

5. Passive immunotherapies for the next influenza pandemic;Reviews in Medical Virology;2024-04-18